eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 62
 
Share:
Share:
Original paper

The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas

Barbara Bobek-Billewicz
1
,
Sylwia Heinze
2
,
Krzysztof Majchrzak
3
,
Patrycja Mazgaj
1
,
Anna Hebda
1

  1. Department of Radiology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Poland
  2. Department of Radiology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Cracow Branch, Poland
  3. Department and Clinical Ward of Neurosurgery, Medical University of Silesia, Sosnowiec, Poland
Folia Neuropathol 2024; 62 (1): 13-20
Online publish date: 2024/03/25
Article file
- The diagnostic (1).pdf  [0.15 MB]
Get citation
 
PlumX metrics:
 
1. Brandão LA, Castillo M. Adult brain tumors: Clinical applications of magnetic resonance spectroscopy. Magn Reson Imaging Clin N Am 2016; 24: 781-809.
2. Brandner S, Jaunmuktane Z. Neurological update: gliomas and other primary brain tumours in adults. J Neurol 2018; 265: 717-727.
3. Bulik M, Jancalek R, Vanicek J, Skoch A, Mechl M. Potential of MR spectroscopy for assessment of glioma grading. Clin Neurol Neurosurg 2013; 115: 146-153.
4. Chawla S, Lee SC, Mohan S, Wang S, Nasrallah M, Vossough A, Krejza J, Melhem ER, Nabavizadeh SA. Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas. Neuroradiol J 2019; 32: 250-258.
5. Ditter P, Hattingen E. MR-Spektroskopie bei Hirntumoren. Radiologe 2017; 57: 450-458.
6. Fountas KN, Kapsalaki EZ, Vogel RL, Fezoulidis I, Robinson JS, Gotsis ED. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 2004; 82: 90-97.
7. Izquierdo C, Joubert B, Ducray F. Anaplastic gliomas in adults: an update. Curr Opin Oncol 2017; 29: 434-442.
8. Kousi E, Tsougos I, Tsolaki E, Fountas KN, Theodorou K, Fezoulidis I, Kapsalaki E, Kappas C. Spectroscopic evaluation of glioma grading at 3T: The combined role of short and long TE. Scientific World Journal 2012; 2012: 546171.
9. Liu ZL, Zhou Q, Zeng QS, Li CF, Zhang K. Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy. J Int Med Res 2012; 40: 76-84.
10. Londoño A, Castillo M, Armao D, Kwock L, Suzuki K. Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels. AJNR Am J Neuroradiol 2003; 24: 942-945.
11. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021; 23: 1231-1251.
12. Naser RKA, Hassan AAK, Shabana AM, Omar NN. Role of magnetic resonance spectroscopy in grading of primary brain tumors. Egypt J Radiol Nucl Med 2016; 47: 577-584.
13. Rafique Z, Awan MW, Iqbal S, Usmani NN, Kamal MM, Arshad W, Ahmad M, Mumtaz H, Ahmad S, Hasan M. Diagnostic accuracy of magnetic resonance spectroscopy in predicting the grade of glioma keeping histopathology as the gold standard. Cureus 2022; 14: e22056.
14. Ramli N, Khairy AM, Seow P, Tan LK, Wong JHD, Ganesan D, Rahmat K. Novel application of chemical shift gradient echo in- and opposed-phase sequences in 3 T MRI for the detection of H-MRS visible lipids and grading of glioma. Eur Radiol 2016; 26: 2019-2029.
15. S AJ, Jose T. Role of magnetic resonance spectroscopy in grading of gliomas-a tertiary care centre study. Int J Res Med Sci 2022; 10: 381-387.
16. Saraf-Lavi E, Bowen BC, Pattany PM, Sklar EML, Murdoch JB, Petito CK. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels. AJNR Am J Neuroradiol 2003; 24: 946-951.
17. Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ. 2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data. Neuro Oncol 2018; 20: 1573-1583.
18. Vamvakas A, Williams SC, Theodorou K, Kapsalaki E, Fountas K, Kappas C, Vassiou K, Tsougos I. Imaging biomarker analysis of advanced multiparametric MRI for glioma grading. Phys Med 2019; 60: 188-198.
19. Vuori K, Kankaanranta L, Häkkinen AM, Gaily E, Valanne L, Granström ML, Joensuu K, Blomstedt G, Paetau A, Lundbom N. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 2004; 230: 703-708.
20. Wei J, Yang G, Hao X, Gu D, Tan Y, Wang X, Dong D, Zhang S, Wang L, Zhang H, Tian J. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication. Eur Radiol 2019; 29: 877-888.
21. Weis J, Ring P, Olofsson T, Ortiz-Nieto F, Wikström J. Short echo time MR spectroscopy of brain tumors: grading of cerebral gliomas by correlation analysis of normalized spectral amplitudes. J Magn Reson Imaging 2010; 31: 39-45.
Copyright: © 2024 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.